Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 7 Stomach Neoplasms 2 Neoplasms 2 Warts 1 Uterine Cervical Neoplasms 1 Stomatitis 1 Solitary Pulmonary Nodule 1 Shock, Septic 1 Pain, Postoperative 1 Neoplasm Metastasis 1 Multiple Pulmonary Nodules 1 Melanoma 1 Lymphedema 1 Lymphatic Metastasis 1 Lung Neoplasms 1 Head and Neck Neoplasms 1 Gastrointestinal Neoplasms 1 Emergence Delirium 1 Disease 1 Colorectal Neoplasms 1

Interventions

Vasopressins 1 Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization 1 Saline Solution 1 Norepinephrine 1 Methylene Blue 1 Contraceptives, Oral 1 Blood Specimen Collection 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Shock, Septic × Methylene Blue × Clear all

NCT06005558 2024-07-05

Low Dose Versus High Dose Methylene Blue in Septic Patients

National Cancer Institute, Egypt

Phase 2/3 Completed

Shock, Septic

Data powered by HemOnc (CC BY 4.0) Colophon ⚡